INmune Bio (INMB) Earnings Date, Estimates & Call Transcripts → Buy Alert (From TradingTips) (Ad) Free INMB Stock Alerts $10.37 +0.45 (+4.54%) (As of 02:44 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 5EstimatedActual EPS (May. 9) -$0.61 Missed By -$0.61 Read Call TranscriptListen to Call Get INmune Bio Earnings AlertsEnter your email address below to receive the latest news and earnings results for INMB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueINMB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INMB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad TradingTipsBuy AlertImagine knowing, ahead of time, what the best investments of the year would be… Well, investors no longer need to imagine, guess, or throw darts. See, we’ve uncovered what looks to be a list of THE 10 best opportunities for 2024.Click here for your FREE report: 10 Great Stocks Under $10 INMB Earnings Date and InformationINmune Bio last announced its earnings results on May 9th, 2024. The reported ($0.61) earnings per share (EPS) for the quarter. The business had revenue of $0.01 million for the quarter. INmune Bio has generated ($1.92) earnings per share over the last year (($1.92) diluted earnings per share). INmune Bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.Read More INmune Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/5/2024Estimated)------- 5/9/2024Q1 2024-($0.61)($0.61)($0.61)-$0.01 million 3/28/2024Q4 2023-($0.47)($0.47)($0.47)-$0.03 million11/1/2023Q3 2023-($0.48)($0.48)($0.48)-$0.04 million8/7/2023Q2 2023-($0.36)($0.36)($0.36)-$0.05 million5/3/2023Q1 2023-($0.36)($0.36)($0.36)-$0.04 million3/2/2023Q4 2022-($0.32)($0.32)($0.32)-$0.10 million Get the Latest News and Ratings for INMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022($0.59)($0.43)+$0.16($0.43)-$0.10 million8/3/2022Q2 2022($0.50)($0.38)+$0.12($0.38)-$0.02 million 5/5/2022Q1 2022($0.60)($0.39)+$0.21($0.39)-$0.16 million 3/3/2022Q4 2021($0.56)($0.55)+$0.01($0.55)-$0.16 million 11/2/2021Q3 2021($0.43)($0.55)($0.12)($0.55)-$0.01 million 8/3/2021Q2 2021($0.34)($0.44)($0.10)($0.44)-- INmune Bio Earnings - Frequently Asked Questions When is INmune Bio's earnings date? INmune Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on INMB's earnings history. How can I listen to INmune Bio's earnings conference call? The conference call for INmune Bio's latest earnings report can be listened to online. Listen to Conference Call How can I read INmune Bio's conference call transcript? The conference call transcript for INmune Bio's latest earnings report can be read online. Read Transcript How much revenue does INmune Bio generate each year? INmune Bio (NASDAQ:INMB) has a recorded annual revenue of $160,000.00. How much profit does INmune Bio generate each year? INmune Bio (NASDAQ:INMB) has a recorded net income of -$30.01 million. INMB has generated -$1.92 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: ABOS Earnings Date ZURA Earnings Date KOD Earnings Date ADVM Earnings Date CGEN Earnings Date ELEV Earnings Date IPSC Earnings Date XFOR Earnings Date CMPX Earnings Date CLLS Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:INMB) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.